Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group
Publication year
2013Author(s)
Source
Leukemia & Lymphoma, 54, 3, (2013), pp. 472-5ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Laboratory of Hematology
Tumorimmunology
Haematology
Journal title
Leukemia & Lymphoma
Volume
vol. 54
Issue
iss. 3
Page start
p. 472
Page end
p. 5
Subject
ONCOL 3: Translational research; ONCOL 3: Translational research NCMLS 2: Immune Regulation; Laboratory Medicine Radboud University Medical CenterAbstract
An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.
This item appears in the following Collection(s)
- Academic publications [246764]
- Faculty of Medical Sciences [93461]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.